Dasgupta T, Rao A R, Yadava P K
Cancer Biology and Applied Molecular Biology Laboratories, School of Life Sciences, Jawaharlal Nehru University, New Delhi, India.
Phytomedicine. 2004 Feb;11(2-3):139-51. doi: 10.1078/0944-7113-00289.
Basil or sweet basil (Ocimum basilicum) is cultivated throughout India and is known for its medicinal value. The effects of doses of 200 and 400 mg/kg body weight of hydroalcoholic extract (80% ethanol, 20% water) of the fresh leaves of Ocimum basilicum on xenobiotic metabolizing Phase I and Phase II enzymes, antioxidant enzymes, Glutathione content, Lactate dehydrogenase and lipid peroxidation in the liver of 8-9 weeks old Swiss albino mice were examined. Furthermore, the anticarcinogenic potential of basil leaf extract was studied, using the model of Benzo(a)pyrene-induced forestomach and 7,12 dimethyl benz(a)anthracene (DMBA)-initiated skin papillomagenesis. The hepatic glutathione S-transferase and DT-diaphorase specific activities were elevated above basal level by basil leaf treatment (from p < 0.005 to p < 0.001). Basil leaf extract was very effective in elevating antioxidant enzyme response by increasing significantly the hepatic glutathione reductase (GR) (p < 0.005), superoxide dismutase (SOD) (p < 0.05), and catalase activities (p < 0.005). Reduced glutathione (GSH), the major intracellular antioxidant, showed a significant elevation in the liver (p < 0.005) and also in all the extrahepatic organs (from p < 0.05 to p < 0.005). In the forestomach, kidney and lung, glutathione S-transferase and DT-diaphorase levels were augmented significantly, varying from p < 0.01 to p < 0.001. There were significant decreases in lipid peroxidation and lactate dehydrogenase activity. Chemopreventive response was evident from the reduced tumor burden (the average number of papillomas/mouse, p < 0.005 to p < 0.001), as well as from the reduced percentage of tumor bearing-animals. Basil leaf, as deduced from the results, augmented mainly the Phase II enzyme activity that is associated with detoxification of xenobiotics, while inhibiting the Phase I enzyme activity. There was an induction in antioxidant level that correlates with the significant reduction of lipid peroxidation and lactate dehydrogenase formation. Moreover, Basil leaf extract was highly effective in inhibiting carcinogen-induced tumor incidence in both the tumor models at peri-initiational level.
罗勒或甜罗勒(唇形科罗勒属植物)在印度各地均有种植,且因其药用价值而闻名。本研究检测了8 - 9周龄瑞士白化小鼠肝脏中,唇形科罗勒属植物鲜叶的水醇提取物(80%乙醇,20%水)剂量为200和400 mg/kg体重时,对外源化合物代谢I相和II相酶、抗氧化酶、谷胱甘肽含量、乳酸脱氢酶及脂质过氧化的影响。此外,利用苯并(a)芘诱导的前胃肿瘤模型和7,12 - 二甲基苯并(a)蒽(DMBA)引发的皮肤乳头状瘤模型,研究了罗勒叶提取物的抗癌潜力。罗勒叶处理使肝脏中谷胱甘肽S - 转移酶和DT - 黄递酶的比活性高于基础水平(p < 0.005至p < 0.001)。罗勒叶提取物通过显著提高肝脏中谷胱甘肽还原酶(GR)(p < 0.005)、超氧化物歧化酶(SOD)(p < 0.05)和过氧化氢酶活性(p < 0.005),非常有效地提高了抗氧化酶反应。细胞内主要的抗氧化剂还原型谷胱甘肽(GSH)在肝脏中显著升高(p < 0.005),在所有肝外器官中也显著升高(p < 0.05至p < 0.005)。在前胃、肾脏和肺中,谷胱甘肽S - 转移酶和DT - 黄递酶水平显著升高,p值范围从< 0.01至< 0.001。脂质过氧化和乳酸脱氢酶活性显著降低。从肿瘤负担减轻(平均每只小鼠的乳头状瘤数量,p < 0.005至p < 0.001)以及荷瘤动物百分比降低可以明显看出化学预防反应。从结果推断,罗勒叶主要增强了与外源化合物解毒相关的II相酶活性,同时抑制了I相酶活性。抗氧化水平的诱导与脂质过氧化和乳酸脱氢酶生成的显著降低相关。此外,罗勒叶提取物在启动期对两种肿瘤模型中致癌物诱导的肿瘤发生率均有高度抑制作用。